Rajat Bhatt, MD
Rheumatology · Richmond, TXNPI 1013938349
Payments from drug & device makers
Across 210 payments — averaging $617.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$57K
- Eli Lilly$34K
- UCB SA$26K
- E.r. Squibb & Sons, L.L.C.$6K
- Mitsubishi Tanabe Pharma Development America, Inc.$3K
- AbbVie$850
- plus $3K from 30 others
What the payments were for
- Food & beverage$4,277100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 5 | $56,603 |
| Eli Lilly | 5 | $33,966 |
| UCB SA | 16 | $25,840 |
| E.r. Squibb & Sons, L.L.C. | 6 | $6,410 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 1 | $2,750 |
| AbbVie | 38 | $850 |
| Lilly USA, LLC | 25 | $485 |
| Amgen(2 entities) | 23 | $445 |
| UCB, Inc. | 9 | $289 |
| Fidia Pharma USA Inc. | 20 | $249 |
| AstraZeneca(2 entities) | 11 | $198 |
| Johnson & Johnson | 8 | $169 |
| GSK | 8 | $132 |
| Organogenesis Inc. | 2 | $129 |
| Abbott | 1 | $127 |
| Boehringer Ingelheim | 4 | $100 |
| Silk Road Medical, Inc. | 1 | $97 |
| Paratek Pharmaceuticals, Inc. | 1 | $96 |
| Pfizer | 5 | $93 |
| Pulmonx Corporation | 1 | $92 |
| Impulse Dynamics (USA) Inc. | 1 | $87 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $74 |
| Octapharma USA, Inc. | 1 | $51 |
| Ultragenyx Pharmaceutical Inc. | 2 | $46 |
| Bristol Myers Squibb | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Cumberland Pharmaceuticals, Inc. | 2 | $26 |
| Radius Health, Inc. | 1 | $25 |
| Novartis | 1 | $22 |
| Oxford Immunotec USA Inc | 1 | $21 |
| Insulet Corporation | 1 | $21 |
| Sanofi | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mitra Clip system$127
- Humira$125
- ELIQUIS$124
- Cimzia$120
How this compares
$129,669 in reported general payments places this provider in the 80th percentile of 512 rheumatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 19 | $127,197 |
| Celecoxib | 103 | $3,884 |
| Hydroxychloroquine Sulfate | 97 | $2,059 |
| MethotrexateMethotrexate Sodium | 86 | $1,194 |
| Diclofenac Sodium | 14 | $404 |
| Alendronate Sodium | 52 | $263 |
| Tramadol Hcl | 32 | $179 |
| Prednisone | 19 | $158 |
| Naproxen | 16 | $146 |
| Folic Acid | 23 | $133 |
| Duloxetine Hcl | 12 | $109 |
| Allopurinol | 16 | $78 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Richmond
- Paul PickrellAustin$40.9M
- Atul SinghalMesquite$13.9M
- Shaikh AliTomball$9.8M
- Jitendra VasandaniLubbock$6.4M
- Dhiman BasuColleyville$6.2M
- Tamar BrionezThe Woodlands$5.2M
- Philip WallerHouston$4.9M
- John CushDallas$3.9M
- Sabeen NajamBaytown$3.6M
- Sanjay ChabraEl Paso$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.